Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
50.53
-1.61 (-3.09%)
Jun 24, 2026, 2:46 PM EDT - Market open
Spruce Biosciences Market Cap
Spruce Biosciences has a market cap or net worth of $139.07 million as of June 24, 2026. Its market cap has increased by 4,966.33% in one year.
Market Cap
139.07M
Enterprise Value
96.55M
1-Year Change
4,966.33%
Ranking
Category
Stock Price
$50.53
Market Cap Chart
Since October 9, 2020, Spruce Biosciences's market cap has decreased from $378.48M to $139.07M, a decrease of -63.25%. That is a compound annual growth rate of -16.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 22, 2026 | 150.55M | 61.46% |
| Dec 31, 2025 | 93.24M | 437.50% |
| Dec 31, 2024 | 17.35M | -85.46% |
| Dec 29, 2023 | 119.28M | 361.35% |
| Dec 30, 2022 | 25.86M | -75.29% |
| Dec 31, 2021 | 104.65M | -81.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kazia Therapeutics | 156.49M |
| Tenaya Therapeutics | 153.42M |
| Corbus Pharmaceuticals Holdings | 153.41M |
| Cognition Therapeutics | 149.46M |
| Tiziana Life Sciences | 149.35M |
| Enlivex | 147.04M |
| Alpha Cognition | 146.76M |
| Molecular Partners AG | 143.54M |